Literature DB >> 33452090

Perceptions of Patients with Primary Nonadherence to Statin Medications.

Derjung M Tarn1, Maureen Barrientos1, Mark J Pletcher1, Keith Cox1, Jon Turner1, Alicia Fernandez1, Janice B Schwartz1.   

Abstract

BACKGROUND: Despite emphasis on efforts to prevent cardiovascular disease (CVD), 13% to 34% of people never fill a prescribed statin (primary nonadherence). This study determined perceptions of adults with primary nonadherence to statins.
METHODS: Ten focus groups were conducted with 61 adults reporting primary nonadherence to statins (93% without known CVD). Participants were recruited from an academic medical center and nationwide Internet advertisements.
RESULTS: Major themes related to primary nonadherence were 1) desire to pursue alternatives before starting a statin (eg, diet and/or exercise, dietary supplements), 2) worry about risks and adverse effects of statins, 3) perceptions of good personal health (suggesting that a statin was not needed), and 4) doubt about the benefits of statins in the absence of disease. Additional themes included mistrust of the pharmaceutical industry, mistrust of prescribing providers, inadequate provider communication about statins, and negative prior experiences with medication. Although rare, a few patients said that high cholesterol does not require treatment if it is genetic. One third noted during focus group discussions that they did not communicate their decision not to take a statin to providers.
CONCLUSIONS: Adults with primary nonadherence to statins describe seeking alternatives, avoiding perceived risks of statins, poor acceptance/understanding of CVD risk estimates, and doubts about the benefits of statins. Many do not disclose their decisions to providers, thus highlighting the need for provider awareness of the potential for primary nonadherence at the point of prescribing, and the need for future work to develop strategies to identify patients with potential primary nonadherence. © Copyright 2021 by the American Board of Family Medicine.

Entities:  

Keywords:  Cardiovascular Diseases; Focus Groups; Hypercholesterolemia; Hyperlipidemias; Medication Adherence; Qualitative Research; Statins

Mesh:

Substances:

Year:  2021        PMID: 33452090      PMCID: PMC8903053          DOI: 10.3122/jabfm.2021.01.200262

Source DB:  PubMed          Journal:  J Am Board Fam Med        ISSN: 1557-2625            Impact factor:   2.657


  26 in total

Review 1.  Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond.

Authors:  Donald M Lloyd-Jones; Yuling Hong; Darwin Labarthe; Dariush Mozaffarian; Lawrence J Appel; Linda Van Horn; Kurt Greenlund; Stephen Daniels; Graham Nichol; Gordon F Tomaselli; Donna K Arnett; Gregg C Fonarow; P Michael Ho; Michael S Lauer; Frederick A Masoudi; Rose Marie Robertson; Véronique Roger; Lee H Schwamm; Paul Sorlie; Clyde W Yancy; Wayne D Rosamond
Journal:  Circulation       Date:  2010-01-20       Impact factor: 29.690

2.  2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Scott M Grundy; Neil J Stone; Alison L Bailey; Craig Beam; Kim K Birtcher; Roger S Blumenthal; Lynne T Braun; Sarah de Ferranti; Joseph Faiella-Tommasino; Daniel E Forman; Ronald Goldberg; Paul A Heidenreich; Mark A Hlatky; Daniel W Jones; Donald Lloyd-Jones; Nuria Lopez-Pajares; Chiadi E Ndumele; Carl E Orringer; Carmen A Peralta; Joseph J Saseen; Sidney C Smith; Laurence Sperling; Salim S Virani; Joseph Yeboah
Journal:  J Am Coll Cardiol       Date:  2018-11-10       Impact factor: 24.094

3.  2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Scott M Grundy; Neil J Stone; Alison L Bailey; Craig Beam; Kim K Birtcher; Roger S Blumenthal; Lynne T Braun; Sarah de Ferranti; Joseph Faiella-Tommasino; Daniel E Forman; Ronald Goldberg; Paul A Heidenreich; Mark A Hlatky; Daniel W Jones; Donald Lloyd-Jones; Nuria Lopez-Pajares; Chiadi E Ndumele; Carl E Orringer; Carmen A Peralta; Joseph J Saseen; Sidney C Smith; Laurence Sperling; Salim S Virani; Joseph Yeboah
Journal:  Circulation       Date:  2018-11-10       Impact factor: 29.690

4.  Systematic Review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Peter W F Wilson; Tamar S Polonsky; Michael D Miedema; Amit Khera; Andrzej S Kosinski; Jeffrey T Kuvin
Journal:  Circulation       Date:  2018-11-10       Impact factor: 29.690

5.  Characteristics of patients with primary non-adherence to medications for hypertension, diabetes, and lipid disorders.

Authors:  Marsha A Raebel; Jennifer L Ellis; Nikki M Carroll; Elizabeth A Bayliss; Brandy McGinnis; Emily B Schroeder; Susan Shetterly; Stan Xu; John F Steiner
Journal:  J Gen Intern Med       Date:  2011-08-31       Impact factor: 5.128

6.  Physician communication when prescribing new medications.

Authors:  Derjung M Tarn; John Heritage; Debora A Paterniti; Ron D Hays; Richard L Kravitz; Neil S Wenger
Journal:  Arch Intern Med       Date:  2006-09-25

7.  Which providers should communicate which critical information about a new medication? Patient, pharmacist, and physician perspectives.

Authors:  Derjung M Tarn; Debora A Paterniti; Bradley R Williams; Camille S Cipri; Neil S Wenger
Journal:  J Am Geriatr Soc       Date:  2009-01-17       Impact factor: 5.562

8.  Provider and patient expectations for dietary supplement discussions.

Authors:  Derjung M Tarn; Jennifer R Guzmán; Jeffrey S Good; Neil S Wenger; Ian D Coulter; Debora A Paterniti
Journal:  J Gen Intern Med       Date:  2014-05-30       Impact factor: 5.128

9.  Primary nonadherence to statin therapy: patients' perceptions.

Authors:  Teressa N Harrison; Stephen F Derose; T Craig Cheetham; Vicki Chiu; Southida S Vansomphone; Kellie Green; Kaan Tunceli; Ronald D Scott; Elizabeth Marrett; Kristi Reynolds
Journal:  Am J Manag Care       Date:  2013-04-01       Impact factor: 2.229

10.  Primary nonadherence to medications in an integrated healthcare setting.

Authors:  Janet Shin; Jeffrey S McCombs; Robert J Sanchez; Margarita Udall; Michael C Deminski; T Craig Cheetham
Journal:  Am J Manag Care       Date:  2012-08       Impact factor: 2.229

View more
  2 in total

1.  Predictors of Informed People's Preferences for Statin Therapy to Reduce Cardiovascular Disease Risk: an Internet Survey Study.

Authors:  K D Valentine; Suzanne Brodney; Karen Sepucha; Michael J Barry
Journal:  J Gen Intern Med       Date:  2022-03-01       Impact factor: 5.128

2.  Primary nonadherence to statin medications: Survey of patient perspectives.

Authors:  Derjung M Tarn; Mark J Pletcher; Rosa Tosqui; Alicia Fernandez; Chi-Hong Tseng; Rachel Moriconi; Douglas S Bell; Maureen Barrientos; Jon A Turner; Janice B Schwartz
Journal:  Prev Med Rep       Date:  2021-03-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.